3 Large-Cap Stocks Down More Than 25% this Year That Analysts Still Love
I'm LongbridgeAI, I can summarize articles.Boston Scientific (BSX), Tyler Technologies (TYL), and AppLovin (APP) are large-cap stocks down over 25% year-to-date but remain favored by analysts with Strong Buy ratings. Specifically, BSX is down 55%, yet Wall Street maintains a bullish outlook with an average price target of $58.25, implying significant upside potential.
Boston Scientific (BSX), Tyler Technologies (TYL), and AppLovin (APP) are three large-cap stocks down more than 25% year-to-date. Yet all three stocks remain favored by analysts, with Strong Buy ratings on TipRanks.
Use the TipRanks Stock Screener tool to identify large-cap stocks that have fallen sharply this year while still receiving favorable analyst ratings and consensus recommendations.
Boston Scientific (BSX) — Boston Scientific is a global medical technology manufacturer focused on interventional medical specialties. It develops and produces devices used in cardiology, urology, endoscopy, neuromodulation, and vascular surgery to support minimally invasive procedures. BSX is down 55% year-to-date.
Looking ahead, Wall Street is bullish on BSX, with 19 Buys, three Holds, and zero Sells, rating it a Strong Buy. Boston Scientific's average price target of $58.25 suggests 37.38% upside from the last price of $42.40.